United Kingdom

People: Amedisys Inc (AMED.OQ)

AMED.OQ on NASDAQ Stock Exchange Global Select Market

5:15pm BST
Change (% chg)

$2.18 (+1.67%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Kemmerly, David 

Mr. David L. Kemmerly is General Counsel of Amedisys, Inc. He is our General Counsel (since October 2015). He previously served as Interim General Counsel from March 30, 2015 to October 30, 2015. Mr. Kemmerly has over 26 years of experience in governmental affairs, with more than 18 years specializing in health care law and public policy. From September 2013 to March 2015, he served as Special Counsel at Adams and Reese LLP, a multidisciplinary law firm where he represented diverse health care interests before the state legislature and state agencies. Prior to Adams and Reese, Mr. Kemmerly served as Director of State Public Affairs of Humana, Inc. for six years where he was responsible for legislative and regulatory affairs and outcomes in all 50 states. In this role, he developed and led implementation of successful state legislative and regulatory strategies that helped protect the business interests of one of the nation’s largest health insurers with over 13 million medical enrollees. Mr. Kemmerly has extensive experience in state and national government relations, including serving as Associate Director of the Department of Government Affairs for the Louisiana State Medical Society where he lobbied state legislators, state regulatory agencies, and the U.S. Congress on issues impacting physicians and the practice of medicine. He also served as an attorney for the Louisiana State Senate, a political consultant for DLK Consulting Group, and on the staffs of a Governor and member of Congress.

Basic Compensation

Total Annual Compensation, USD 395,673
Restricted Stock Award, USD 196,031
Long-Term Incentive Plans, USD --
All Other, USD 500,910
Fiscal Year Total, USD 1,092,610

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 18,750 1,517,370.00
Name Fiscal Year Total

Donald Washburn


Paul Kusserow


Scott Ginn


Christopher Gerard


Sharon Brunecz


Michael North

As Of  31 Dec 2018